Reports

Industry Research Reports

Global Plasma Fractionation Technology Market Research Report 2026

Global Plasma Fractionation Technology Market Research Report 2026

Industry: Service & Software

Published Date: 2026-03-06

Pages: 122 Pages

Report ld: 6023714

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Plasma Fractionation Technology Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

7.5%

marketSize

Market Size,2032

USD 62,130

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 40,260 million
Market Forecast in 2032(Value)
US$ 62,130 million
CAGR
7.5%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Plasma Fractionation Technology market was valued at US$ 37710 million in 2025 and is anticipated to reach US$ 62130 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.

Market Drivers:

Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.

Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.

Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.

Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.

Market Challenges:

High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.

Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.

Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.

Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.

The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.

The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.

North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.

This report delivers a comprehensive overview of the global Plasma Fractionation Technology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plasma Fractionation Technology. The Plasma Fractionation Technology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Plasma Fractionation Technology market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Plasma Fractionation Technology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Other

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

marn_i1

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

marn_i1

Chapter 3: Provides a detailed view of the competitive landscape for Plasma Fractionation Technology companies, covering revenue share, development plans, and mergers and acquisitions.

marn_i1

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

marn_i1

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

marn_i1

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Plasma Fractionation Technology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Immune Globulin

1.2.3 Coagulation Factor

1.2.4 Albumin

1.2.5 Other

1.3 Market by Application

1.3.1 Global Plasma Fractionation Technology Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Plasma Fractionation Technology Market Perspective (2021–2032)

2.2 Global Plasma Fractionation Technology Growth Trends by Region

2.2.1 Global Plasma Fractionation Technology Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Plasma Fractionation Technology Historic Market Size by Region (2021–2026)

2.2.3 Plasma Fractionation Technology Forecasted Market Size by Region (2027–2032)

2.3 Plasma Fractionation Technology Market Dynamics

2.3.1 Plasma Fractionation Technology Industry Trends

2.3.2 Plasma Fractionation Technology Market Drivers

2.3.3 Plasma Fractionation Technology Market Challenges

2.3.4 Plasma Fractionation Technology Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Plasma Fractionation Technology Players by Revenue

3.1.1 Global Top Plasma Fractionation Technology Players by Revenue (2021–2026)

3.1.2 Global Plasma Fractionation Technology Revenue Market Share by Players (2021–2026)

3.2 Global Top Plasma Fractionation Technology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Plasma Fractionation Technology Revenue

3.4 Global Plasma Fractionation Technology Market Concentration Ratio

3.4.1 Global Plasma Fractionation Technology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Plasma Fractionation Technology Revenue in 2025

3.5 Global Key Players of Plasma Fractionation Technology Head Offices and Areas Served

3.6 Global Key Players of Plasma Fractionation Technology, Products and Applications

3.7 Global Key Players of Plasma Fractionation Technology, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

muLu

4 Plasma Fractionation Technology Breakdown Data by Type

4.1 Global Plasma Fractionation Technology Historic Market Size by Type (2021–2026)

4.2 Global Plasma Fractionation Technology Forecasted Market Size by Type (2027–2032)

muLu

5 Plasma Fractionation Technology Breakdown Data by Application

5.1 Global Plasma Fractionation Technology Historic Market Size by Application (2021–2026)

5.2 Global Plasma Fractionation Technology Forecasted Market Size by Application (2027–2032)

muLu

6 North America

6.1 North America Plasma Fractionation Technology Market Size (2021–2032)

6.2 North America Plasma Fractionation Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Plasma Fractionation Technology Market Size by Country (2021–2026)

6.4 North America Plasma Fractionation Technology Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Plasma Fractionation Technology Market Size (2021–2032)

7.2 Europe Plasma Fractionation Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Plasma Fractionation Technology Market Size by Country (2021–2026)

7.4 Europe Plasma Fractionation Technology Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

muLu

8 Asia-Pacific

8.1 Asia-Pacific Plasma Fractionation Technology Market Size (2021–2032)

8.2 Asia-Pacific Plasma Fractionation Technology Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Plasma Fractionation Technology Market Size by Region (2021–2026)

8.4 Asia-Pacific Plasma Fractionation Technology Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

muLu

9 Latin America

9.1 Latin America Plasma Fractionation Technology Market Size (2021–2032)

9.2 Latin America Plasma Fractionation Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Plasma Fractionation Technology Market Size by Country (2021–2026)

9.4 Latin America Plasma Fractionation Technology Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Plasma Fractionation Technology Market Size (2021–2032)

10.2 Middle East & Africa Plasma Fractionation Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Plasma Fractionation Technology Market Size by Country (2021–2026)

10.4 Middle East & Africa Plasma Fractionation Technology Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Details

11.1.2 Takeda Business Overview

11.1.3 Takeda Plasma Fractionation Technology Introduction

11.1.4 Takeda Revenue in Plasma Fractionation Technology Business (2021–2026)

11.1.5 Takeda Recent Development

11.2 CSL

11.2.1 CSL Company Details

11.2.2 CSL Business Overview

11.2.3 CSL Plasma Fractionation Technology Introduction

11.2.4 CSL Revenue in Plasma Fractionation Technology Business (2021–2026)

11.2.5 CSL Recent Development

11.3 Grifols

11.3.1 Grifols Company Details

11.3.2 Grifols Business Overview

11.3.3 Grifols Plasma Fractionation Technology Introduction

11.3.4 Grifols Revenue in Plasma Fractionation Technology Business (2021–2026)

11.3.5 Grifols Recent Development

11.4 Octapharma

11.4.1 Octapharma Company Details

11.4.2 Octapharma Business Overview

11.4.3 Octapharma Plasma Fractionation Technology Introduction

11.4.4 Octapharma Revenue in Plasma Fractionation Technology Business (2021–2026)

11.4.5 Octapharma Recent Development

11.5 Kedrion

11.5.1 Kedrion Company Details

11.5.2 Kedrion Business Overview

11.5.3 Kedrion Plasma Fractionation Technology Introduction

11.5.4 Kedrion Revenue in Plasma Fractionation Technology Business (2021–2026)

11.5.5 Kedrion Recent Development

11.6 LFB Group

11.6.1 LFB Group Company Details

11.6.2 LFB Group Business Overview

11.6.3 LFB Group Plasma Fractionation Technology Introduction

11.6.4 LFB Group Revenue in Plasma Fractionation Technology Business (2021–2026)

11.6.5 LFB Group Recent Development

11.7 Biotest

11.7.1 Biotest Company Details

11.7.2 Biotest Business Overview

11.7.3 Biotest Plasma Fractionation Technology Introduction

11.7.4 Biotest Revenue in Plasma Fractionation Technology Business (2021–2026)

11.7.5 Biotest Recent Development

11.8 BPL

11.8.1 BPL Company Details

11.8.2 BPL Business Overview

11.8.3 BPL Plasma Fractionation Technology Introduction

11.8.4 BPL Revenue in Plasma Fractionation Technology Business (2021–2026)

11.8.5 BPL Recent Development

11.9 RAAS

11.9.1 RAAS Company Details

11.9.2 RAAS Business Overview

11.9.3 RAAS Plasma Fractionation Technology Introduction

11.9.4 RAAS Revenue in Plasma Fractionation Technology Business (2021–2026)

11.9.5 RAAS Recent Development

11.10 CBPO

11.10.1 CBPO Company Details

11.10.2 CBPO Business Overview

11.10.3 CBPO Plasma Fractionation Technology Introduction

11.10.4 CBPO Revenue in Plasma Fractionation Technology Business (2021–2026)

11.10.5 CBPO Recent Development

11.11 Hualan Bio

11.11.1 Hualan Bio Company Details

11.11.2 Hualan Bio Business Overview

11.11.3 Hualan Bio Plasma Fractionation Technology Introduction

11.11.4 Hualan Bio Revenue in Plasma Fractionation Technology Business (2021–2026)

11.11.5 Hualan Bio Recent Development

11.12 Tiantan Bio

11.12.1 Tiantan Bio Company Details

11.12.2 Tiantan Bio Business Overview

11.12.3 Tiantan Bio Plasma Fractionation Technology Introduction

11.12.4 Tiantan Bio Revenue in Plasma Fractionation Technology Business (2021–2026)

11.12.5 Tiantan Bio Recent Development

11.13 Shuanglin Bio

11.13.1 Shuanglin Bio Company Details

11.13.2 Shuanglin Bio Business Overview

11.13.3 Shuanglin Bio Plasma Fractionation Technology Introduction

11.13.4 Shuanglin Bio Revenue in Plasma Fractionation Technology Business (2021–2026)

11.13.5 Shuanglin Bio Recent Development

11.14 Boya Bio

11.14.1 Boya Bio Company Details

11.14.2 Boya Bio Business Overview

11.14.3 Boya Bio Plasma Fractionation Technology Introduction

11.14.4 Boya Bio Revenue in Plasma Fractionation Technology Business (2021–2026)

11.14.5 Boya Bio Recent Development

11.15 Yuanda Shuyang

11.15.1 Yuanda Shuyang Company Details

11.15.2 Yuanda Shuyang Business Overview

11.15.3 Yuanda Shuyang Plasma Fractionation Technology Introduction

11.15.4 Yuanda Shuyang Revenue in Plasma Fractionation Technology Business (2021–2026)

11.15.5 Yuanda Shuyang Recent Development

11.16 Weiguang Bio

11.16.1 Weiguang Bio Company Details

11.16.2 Weiguang Bio Business Overview

11.16.3 Weiguang Bio Plasma Fractionation Technology Introduction

11.16.4 Weiguang Bio Revenue in Plasma Fractionation Technology Business (2021–2026)

11.16.5 Weiguang Bio Recent Development

11.17 Nanyue Bio

11.17.1 Nanyue Bio Company Details

11.17.2 Nanyue Bio Business Overview

11.17.3 Nanyue Bio Plasma Fractionation Technology Introduction

11.17.4 Nanyue Bio Revenue in Plasma Fractionation Technology Business (2021–2026)

11.17.5 Nanyue Bio Recent Development

11.18 KM Biologics

11.18.1 KM Biologics Company Details

11.18.2 KM Biologics Business Overview

11.18.3 KM Biologics Plasma Fractionation Technology Introduction

11.18.4 KM Biologics Revenue in Plasma Fractionation Technology Business (2021–2026)

11.18.5 KM Biologics Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Plasma Fractionation Technology Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Immune Globulin
Table 3. Key Players of Coagulation Factor
Table 4. Key Players of Albumin
Table 5. Key Players of Other
Table 6. Global Plasma Fractionation Technology Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Plasma Fractionation Technology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Plasma Fractionation Technology Market Size by Region (US$ Million), 2021–2026
Table 9. Global Plasma Fractionation Technology Market Share by Region (2021–2026)
Table 10. Global Plasma Fractionation Technology Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Plasma Fractionation Technology Market Share by Region (2027–2032)
Table 12. Plasma Fractionation Technology Market Trends
Table 13. Plasma Fractionation Technology Market Drivers
Table 14. Plasma Fractionation Technology Market Challenges
Table 15. Plasma Fractionation Technology Market Restraints
Table 16. Global Plasma Fractionation Technology Revenue by Players (US$ Million), 2021–2026
Table 17. Global Plasma Fractionation Technology Market Share by Players (2021–2026)
Table 18. Global Top Plasma Fractionation Technology Players by Tier (Tier 1, Tier 2, and Tier 3), based on Plasma Fractionation Technology Revenue, 2025
Table 19. Ranking of Global Top Plasma Fractionation Technology Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Plasma Fractionation Technology Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Plasma Fractionation Technology, Headquarters and Area Served
Table 22. Global Key Players of Plasma Fractionation Technology, Products and Applications
Table 23. Global Key Players of Plasma Fractionation Technology, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Plasma Fractionation Technology Market Size by Type (US$ Million), 2021–2026
Table 26. Global Plasma Fractionation Technology Revenue Market Share by Type (2021–2026)
Table 27. Global Plasma Fractionation Technology Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Plasma Fractionation Technology Revenue Market Share by Type (2027–2032)
Table 29. Global Plasma Fractionation Technology Market Size by Application (US$ Million), 2021–2026
Table 30. Global Plasma Fractionation Technology Revenue Market Share by Application (2021–2026)
Table 31. Global Plasma Fractionation Technology Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Plasma Fractionation Technology Revenue Market Share by Application (2027–2032)
Table 33. North America Plasma Fractionation Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Plasma Fractionation Technology Market Size by Country (US$ Million), 2021–2026
Table 35. North America Plasma Fractionation Technology Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Plasma Fractionation Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Plasma Fractionation Technology Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Plasma Fractionation Technology Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Plasma Fractionation Technology Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Plasma Fractionation Technology Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Plasma Fractionation Technology Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Plasma Fractionation Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Plasma Fractionation Technology Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Plasma Fractionation Technology Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Plasma Fractionation Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Plasma Fractionation Technology Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Plasma Fractionation Technology Market Size by Country (US$ Million), 2027–2032
Table 48. Takeda Company Details
Table 49. Takeda Business Overview
Table 50. Takeda Plasma Fractionation Technology Product
Table 51. Takeda Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 52. Takeda Recent Development
Table 53. CSL Company Details
Table 54. CSL Business Overview
Table 55. CSL Plasma Fractionation Technology Product
Table 56. CSL Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 57. CSL Recent Development
Table 58. Grifols Company Details
Table 59. Grifols Business Overview
Table 60. Grifols Plasma Fractionation Technology Product
Table 61. Grifols Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 62. Grifols Recent Development
Table 63. Octapharma Company Details
Table 64. Octapharma Business Overview
Table 65. Octapharma Plasma Fractionation Technology Product
Table 66. Octapharma Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Details
Table 69. Kedrion Business Overview
Table 70. Kedrion Plasma Fractionation Technology Product
Table 71. Kedrion Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Details
Table 74. LFB Group Business Overview
Table 75. LFB Group Plasma Fractionation Technology Product
Table 76. LFB Group Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 77. LFB Group Recent Development
Table 78. Biotest Company Details
Table 79. Biotest Business Overview
Table 80. Biotest Plasma Fractionation Technology Product
Table 81. Biotest Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 82. Biotest Recent Development
Table 83. BPL Company Details
Table 84. BPL Business Overview
Table 85. BPL Plasma Fractionation Technology Product
Table 86. BPL Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 87. BPL Recent Development
Table 88. RAAS Company Details
Table 89. RAAS Business Overview
Table 90. RAAS Plasma Fractionation Technology Product
Table 91. RAAS Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 92. RAAS Recent Development
Table 93. CBPO Company Details
Table 94. CBPO Business Overview
Table 95. CBPO Plasma Fractionation Technology Product
Table 96. CBPO Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 97. CBPO Recent Development
Table 98. Hualan Bio Company Details
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Plasma Fractionation Technology Product
Table 101. Hualan Bio Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 102. Hualan Bio Recent Development
Table 103. Tiantan Bio Company Details
Table 104. Tiantan Bio Business Overview
Table 105. Tiantan Bio Plasma Fractionation Technology Product
Table 106. Tiantan Bio Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 107. Tiantan Bio Recent Development
Table 108. Shuanglin Bio Company Details
Table 109. Shuanglin Bio Business Overview
Table 110. Shuanglin Bio Plasma Fractionation Technology Product
Table 111. Shuanglin Bio Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 112. Shuanglin Bio Recent Development
Table 113. Boya Bio Company Details
Table 114. Boya Bio Business Overview
Table 115. Boya Bio Plasma Fractionation Technology Product
Table 116. Boya Bio Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 117. Boya Bio Recent Development
Table 118. Yuanda Shuyang Company Details
Table 119. Yuanda Shuyang Business Overview
Table 120. Yuanda Shuyang Plasma Fractionation Technology Product
Table 121. Yuanda Shuyang Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 122. Yuanda Shuyang Recent Development
Table 123. Weiguang Bio Company Details
Table 124. Weiguang Bio Business Overview
Table 125. Weiguang Bio Plasma Fractionation Technology Product
Table 126. Weiguang Bio Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 127. Weiguang Bio Recent Development
Table 128. Nanyue Bio Company Details
Table 129. Nanyue Bio Business Overview
Table 130. Nanyue Bio Plasma Fractionation Technology Product
Table 131. Nanyue Bio Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 132. Nanyue Bio Recent Development
Table 133. KM Biologics Company Details
Table 134. KM Biologics Business Overview
Table 135. KM Biologics Plasma Fractionation Technology Product
Table 136. KM Biologics Revenue in Plasma Fractionation Technology Business (US$ Million), 2021–2026
Table 137. KM Biologics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
muLu

List of Figures

Figure 1. Plasma Fractionation Technology Picture
Figure 2. Global Plasma Fractionation Technology Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Plasma Fractionation Technology Market Share by Type: 2025 vs 2032
Figure 4. Immune Globulin Features
Figure 5. Coagulation Factor Features
Figure 6. Albumin Features
Figure 7. Other Features
Figure 8. Global Plasma Fractionation Technology Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Plasma Fractionation Technology Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Plasma Fractionation Technology Report Years Considered
Figure 14. Global Plasma Fractionation Technology Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Plasma Fractionation Technology Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Plasma Fractionation Technology Market Share by Region: 2025 vs 2032
Figure 17. Global Plasma Fractionation Technology Market Share by Players in 2025
Figure 18. Global Plasma Fractionation Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Plasma Fractionation Technology Revenue in 2025
Figure 20. North America Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Plasma Fractionation Technology Market Share by Country (2021–2032)
Figure 22. United States Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Plasma Fractionation Technology Market Share by Country (2021–2032)
Figure 26. Germany Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Plasma Fractionation Technology Market Share by Region (2021–2032)
Figure 34. China Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Plasma Fractionation Technology Market Share by Country (2021–2032)
Figure 42. Mexico Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Plasma Fractionation Technology Market Share by Country (2021–2032)
Figure 46. Israel Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Plasma Fractionation Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Takeda Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 50. CSL Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 51. Grifols Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 52. Octapharma Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 53. Kedrion Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 54. LFB Group Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 55. Biotest Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 56. BPL Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 57. RAAS Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 58. CBPO Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 59. Hualan Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 60. Tiantan Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 61. Shuanglin Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 62. Boya Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 63. Yuanda Shuyang Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 64. Weiguang Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 65. Nanyue Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 66. KM Biologics Revenue Growth Rate in Plasma Fractionation Technology Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Plasma Fractionation Technology in 2026?zhanKai
The global market size of Plasma Fractionation Technology in 2026 was 40260 Million USD.
Which companies rank high in the global Plasma Fractionation Technology market?shouQi
What was the global market size of Plasma Fractionation Technology in 2032?shouQi
What is the annual compound growth rate of the global Plasma Fractionation Technology market size from 2026 to 2032?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Global Plasma Fractionation Technology Market Research Report 2026

Industry: Service & Software

Published Date: 2026-03-06

Pages: 122 Pages

Report ld: 6023714

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now